This online activity will explore best practices for the infusion of monoclonal antibodies in patients with mild-to-moderate COVID-19.
Release Date: June 25, 2021
Expiration Date: June 25, 2022
An Animated Whiteboard View: Best Practices in the Management of Opioid Use Disorder
This whiteboard preceptorship is focused on the management of patients with opioid use disorder.
Release Date: March 31, 2020
Expiration Date: March 31, 2021
Personalized Treatment for Patients with Chronic Lymphocytic Leukemia
This case-based enduring activity will cover the treatment of patients with chronic lymphocytic leukemia (CLL) receiving medical care within the Department of Veterans Affairs (VA) system.
Release Date: May 13, 2020
Expiration Date: May 13, 2021
Advances in the Management of Excessive Daytime Sleepiness Due to Either Narcolepsy or Obstructive Sleep Apnea
This online activity is focused on the team involved in the management of patients with excessive daytime sleepiness.
Release Date: May 27, 2020
Expiration Date: May 27, 2021
A Virtual Reality View New Approaches to the Diagnosis and Treatment of Pediatric and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
While guidelines regarding the management of AD in children have been published, variability persists in practice. Treatment inconsistencies and the chronic and relapsing nature of AD can lead to frustration for patients, family, and caregivers when managing AD. This program will focus on providing AD caregivers an update on recent pathophysiological findings that drive new therapeutic targets; reviewing severity and diagnosis of AD; and discussing the clinical profiles of existing and emerging agents, with focus on treatment individualization.
Release Date: June 11, 2020
Expiration Date: June 11, 2021
A Virtual Reality View New Approaches to the Diagnosis and Treatment of Pediatric and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
While guidelines regarding the management of AD in children have been published, variability persists in practice. Treatment inconsistencies and the chronic and relapsing nature of AD can lead to frustration for patients, family, and caregivers when managing AD. This program will focus on providing AD caregivers an update on recent pathophysiological findings that drive new therapeutic targets; reviewing severity and diagnosis of AD; and discussing the clinical profiles of existing and emerging agents, with focus on treatment individualization.
Release Date: June 11, 2020
Expiration Date: June 11, 2021
A Virtual Reality Tour – The Role of Risk Evaluation in Minimizing Recurrence and Metastasis in Patients with cSCC Undergoing Surgical Intervention
This enduring activity is focused on the management of patients with advanced or metastatic cutaneous squamous cell carcinoma.
Release Date: June 12, 2020
Expiration Date: June 12, 2021
This online activity is focused on the management of patients with small cell lung cancer.
Release Date: June 15, 2020
Expiration Date: June 15, 2021
A Virtual Reality View: Selecting Disease-Modifying Therapy for Multiple Sclerosis: Tools to Achieve and Maintain Control of a Dynamic Disease
This activity will cover the treatment and management of patients with multiple sclerosis (MS).
Release Date: June 16, 2020
Expiration Date: June 16, 2021
The Role of the Emergency Room Physician in the Diagnosis and Management of Neuromyelitis Optica Spectrum Disorder
Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare, lifelong and debilitating autoimmune disease of the central nervous system (CNS), characterized by inflammation in the optic nerve and spinal cord. At this time there are no approved drugs to treat NMOSD. This program will focus on recognizing the symptoms and signs of NMOSD, reviewing best practices for early diagnosis of the disease, and discussing the novel mechanisms of action of emerging treatments for NMOSD and clinical trial data on their safety and efficacy profiles.
Release Date: June 30, 2020
Expiration Date: June 30, 2021
A Virtual Reality View: Incorporating GLP-1 Receptor Agonists into Clinical Practice: Personalizing Therapy to Improve Glycemic and Extra-glycemic Outcomes
This case-based activity will cover the diagnosis, treatment, and management of patients with type 2 diabetes.
Release Date: June 30, 2020
Expiration Date: June 30, 2021
Ensuring Optimal Patient Outcomes in the Treatment and Management of Atopic Dermatitis in the Infant and Pediatric Population
This case-based enduring activity will cover the treatment, and management of atopic dermatitis in the infant and pediatric population.
Release Date: June 30, 2020
Expiration Date: June 30, 2021
Ensuring Optimal Patient Outcomes in the Treatment and Management of Atopic Dermatitis in the Infant and Pediatric Population
This case-based enduring activity will cover the treatment, and management of Atopic Dermatitis in the Infant and Pediatric Population
Release Date: July 13, 2020
Expiration Date: July 13, 2021
Diagnosing and Managing Primary Headache Disorders in the Primary Care Setting: Challenges and Opportunities
This case-based enduring activity will cover the treatment and management of patients with headache disorders, including migraine and cluster headache.
Release Date: July 16, 2020
Expiration Date: July 16, 2021
The case-based enduring activity will cover the treatment and management of patients with hepatitis C infection.
Release Date: July 23, 2020
Expiration Date: July 23, 2021
This activity is primarily designed for US-based members of multidisciplinary teams involved in the management of patients with Axial Spondyloarthritis (AxSpA).
Release Date: July 29, 2020
Expiration Date: July 29, 2021
The Role of Risk Evaluation in Minimizing Recurrence and Metastasis in Patients with cSCC Undergoing Surgical Intervention
This enduring activity is focused on the management of patients with advanced or metastatic cutaneous squamous cell carcinoma.
Release Date: Jul 31, 2020
Expiration Date: July 31, 2021
Optimizing the Paradigm Shift Driven by CDK 4/6 Inhibition in Metastatic HR-positive, HER2-negative Breast Cancer
This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.
Release Date: August 7, 2020
Expiration Date: August 7, 2021
This online activity will cover the management of patients with psoriasis.
Release Date: August 14, 2020
Expiration Date: August 14, 2021
This activity targets healthcare gaps related to the identification and understanding of potential therapeutic targets for treating systemic lupus erythematous (SLE), impacting SLE management and potential utilization of targeted treatment.
Release Date: December 17, 2020
Expiration Date: December 17, 2021
This program will explore the use of agents recently granted emergency use authorization for the management of COVID-19. Clinicians will learn about the mechanism of action of monoclonal antibodies against COVID-19, how to identify patients who are at risk for developing severe COVID-19, and discuss best practices on incorporating these agents into clinical practice to prevent the development of severe COVID-19 in recently diagnosed patients. This activity will also explore the use of baricitinib in combination with remdesivir for patients hospitalized with COVID-19 and provide guidance on how to select patients who would benefit from this therapy.
Release Date: December 23, 2020
Expiration Date: December 23, 2021
This case-based online activity will cover the treatment and management of patients with thyroid cancer.
Release Date: December 23, 2020
Expiration Date: December 23, 2021
This online activity targets healthcare gaps related to the treatment and management of atrial fibrillation (AF), impacting outcomes through guidelines and best practices, appropriate antiarrhythmic use and shared decision-making.
Release Date: January 4, 2021
Expiration Date: January 4, 2022
This enduring activity will cover treating and managing atopic dermatitis in pediatric and adolescent patients.
Release Date: January 11, 2021
Expiration Date: January 11, 2022
This online activity will review evidence-based approaches to the diagnosis and management of atopic dermatitis (AD), in addition to associated quality of life issues and adverse events associated with disease and treatment.
Release Date: January 13, 2021
Expiration Date: January 13, 2022
A 3D View – Going Beyond the Practice Guidelines to Leverage Mutations in the Pursuit of Unique Treatment Approaches: Relapsed Follicular Lymphoma
Release Date: January 25, 2021
Expiration Date: January 25, 2022
This case-based enduring activity will cover the treatment and management of patients with diabetes.
Release Date: January 27, 2021
Expiration Date: January 27, 2022
IC-ONC Patient Resources and Tools on Immunotherapy and Immune-Related Adverse Events
This patient-centric activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.
Release Date: January 28, 2021
Expiration Date: January 28, 2022
This COVID-19 FRONTLINE Whiteboard series will explore the role of emerging monoclonal antibody therapies and vaccines in managing the COVID-19 pandemic. Each module will focus on clinical trial data and aid clinicians in identifying patients who would benefit from therapy.
In this module, we will compare the mechanism of action of monoclonal and polyclonal antibodies and evaluate clinical trial evidence on the efficacy and safety of these therapies for the management of COVID-19.
Release Date: February 2, 2021
Expiration Date: February 2, 2022
This COVID-19 FRONTLINE Whiteboard series will explore the role of emerging monoclonal antibody therapies and vaccines in managing the COVID-19 pandemic. Each module will focus on clinical trial data and aid clinicians in identifying patients who would benefit from therapy.
In this module, we will review the mechanism of action of monoclonal antibody therapies and vaccines for the prevention and treatment of COVID-19, and assess the efficacy and safety of these emerging therapies.
Release Date: February 2, 2021
Expiration Date: February 2, 2022
This COVID-19 FRONTLINE Whiteboard series will explore the role of emerging monoclonal antibody therapies and vaccines in managing the COVID-19 pandemic. Each module will focus on clinical trial data and aid clinicians in identifying patients who would benefit from therapy.
In this module, we will investigate the risk of therapy failure due to SARS-CoV-2 mutation with single and dual monoclonal antibody therapies.
Release Date: February 2, 2021
Expiration Date: February 2, 2022
This case-based activity targets healthcare gaps related to the underlying autoimmune causes of alopecia areata (AA) and targeted treatment approaches, which can have a profound impact on health-related quality of life through burden of disease and associated comorbidities.
Release Date: February 9, 2021
Expiration Date: February 9, 2022
This enduring activity will cover the diagnosis, treatment, and management of advanced thyroid cancer.
Release Date: February 10, 2021
Expiration Date: February 10, 2022
This online activity targets healthcare gaps correlated with early intervention in neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME) and diabetic retinopathy (DR) without center-involved macular edema, which can have a profound impact on vision-related quality of life.
Release Date: February 19, 2021
Expiration Date: February 19, 2022
This case-based activity will cover the treatment and management of patients with advanced/metastatic basal cell carcinoma.
Release Date: February 25, 2021
Expiration Date: February 25, 2022
This enduring activity is focused on the care of patients with migraine.
Release Date: February 25, 2021
Expiration Date: February 25, 2022
This case-based activity targets healthcare gaps related to the underlying autoimmune causes of alopecia areata (AA) and targeted treatment approaches, which can have a profound impact on health-related quality of life through burden of disease and associated comorbidities. This content was co-created by Dr. Brett King (New Haven, CT) and Dr. Rodney Sinclair (Melbourne, Australia).
Release Date: February 25, 2021
Expiration Date: February 25, 2022
This case-based enduring activity will cover the treatment and management of patients with diabetes.
Release Date: February 26, 2021
Expiration Date: February 26, 2022
The COVID-19 FRONTLINE TeleECHO program provides a comprehensive and up-to-date perspective on the ever-changing management of patients with COVID-19. This recorded TeleECHO session features in-depth case studies to encourage retention of the lessons and provide new perspectives on the management of patients during the COVID-19 pandemic. The case studies will focus on different issues facing clinicians, such as identifying patients who would benefit from monoclonal antibody therapy and best practices for incorporating agents authorized for emergency use into the care of hospitalized and non-hospitalized patients with COVID-19.
Release Date: March 4, 2021
Expiration Date: March 4, 2022
This case-based enduring activity will cover the epidemiology, pathophysiology, diagnosis, and treatment of eosinophilic esophagitis.
Release Date: March 5, 2021
Expiration Date: March 5, 2022
This enduring activity is focused on the care of patients with migraine.
Release Date: March 9, 2021
Expiration Date: March 9, 2022
This case-based activity will cover the underlying causes of atopic dermatitis along with current and emerging systemic agents as part of the overall treatment plan.
Release Date: March 11, 2021
Expiration Date: March 11, 2022
This activity will cover the treatment and management of patients with psoriatic arthritis during the COVID-19 pandemic.
Release Date: March 23, 2021
Expiration Date: March 23, 2022
The diabetic retinopathy (DR) Immersive Simulation Experience allows learners to engage in clinical decision-making targeting diagnosis and therapeutic approaches in DR management. By participating in this simulated 3D encounter, you will observe patient-provider interactions and use pertinent information from the patients’ electronic chart to decide the next best course of action at various key points in care. Highlighted areas for this activity include assessment of retinopathy severity, intensification of treatment, as well as the recognition and management of adverse events.
Release Date: March 18, 2021
Expiration Date: March 18, 2022
This situation room activity allows learners to practice making clinical decisions in the management of patients with psoriatic arthritis. Learners will view a simulated interaction between a patient and their physician and use information from the patient’s electronic chart to decide the next best course of action. Topics covered in this activity include assessment of disease severity, treatment selection, and managing patients with SARS-CoV-2 infection or exposure.
Release Date: March 18, 2021
Expiration Date: March 18, 2022
This case-based online activity will cover the treatment and management of patients with psoriatic arthritis.
Release Date: March 23, 2021
Expiration Date: March 23, 2022
This case-based activity will cover the causes of atopic dermatitis, the patient burden of AD, and current and emerging systemic agents for use in clinical practice.
Release Date: March 26, 2021
Expiration Date: March 26, 2022
This activity will explore the management of patients with HER2-negative, metastatic gastric cancer and the emerging role of immunotherapy as a first-line treatment option.
Release Date: March 26, 2021
Expiration Date: March 26, 2022
This case-based online activity will cover the treatment and management of patients with psoriatic arthritis.
Release Date: March 26, 2021
Expiration Date: March 26, 2022
This case-based enduring activity will explore treatment options, epidemiology for basal cell carcinoma.
Release Date: April 7, 2021
Expiration Date: April 7, 2022
The AxSpA TeleECHO enduring will explore strategies to promptly recognize, diagnose, and manage patients with axial spondyloarthritis (AxSpA). This program provides an interactive platform that includes didactic programming in addition to case-based discussion on the selection of therapeutic options and the management of patients with AxSpA.
Release Date: March 30, 2021
Expiration Date: March 30, 2022
This activity will allow clinicians to recognize the symptoms of interstitial lung disease, a potentially serious pulmonary toxicity associated with several HER2-targeted therapies for the treatment of cancer. Learners will be able to recognize the signs and symptoms of pulmonary toxicity associated with systemic cancer therapy including interstitial lung disease and pneumonitis.
Release Date: March 30, 2021
Expiration Date: March 30, 2022
The Age-related Macular Degeneration (AMD) Immersive Simulation Experience allows learners to engage in clinical decision-making targeting diagnosis and therapeutic approaches in AMD management. By participating in this simulated 3D encounter, you will observe patient-provider interactions and use pertinent information from the patients’ electronic chart to decide the next best course of action at various key points in care. Highlighted areas for this activity include assessment of AMD classification, risk factor modification, interventions based on AMD classification, as well as the recognition and management of treatment-related adverse events.
Release Date: April 2, 2021
Expiration Date: April 2, 2022
This enduring activity is a faculty-led didactic and case-based lecture focusing on treatment and management of patients with patients with advanced/metastatic basal cell skin cancer.
Release Date: April 2, 2021
Expiration Date: April 2, 2022
This case-based activity will explore the role of surgical oncologists in the management of esophageal cancer, review emerging clinical trial data on the use of immune checkpoint inhibitors as adjuvant therapy, and examine strategies to appropriately sequence therapies using patient-specific factors.
Release Date: April 2, 2021
Expiration Date: April 2, 2022
This online, case-based, practice-focused activity will cover diagnosis and management strategies for headache disorders, including migraine.
Release Date: April 7, 2021
Expiration Date: April 7, 2022
This case-based activity will cover the underlying causes of atopic dermatitis along with current and emerging systemic agents as part of the overall treatment plan.
Release Date: April 8, 2021
Expiration Date: April 8, 2022
The Retinal Vein Occlusion (RVO) Immersive Simulation Experience allows learners to engage in clinical decision-making targeting diagnosis and therapeutic approaches in RVO management. By participating in this simulated 3D encounter, you will observe patient-provider interactions and use pertinent information from the patients’ electronic chart to decide the next best course of action at various key points in care. Highlighted areas for this activity include assessment of RVO classification, risk factor modification, interventions based on RVO classification, as well as the recognition and management of treatment-related adverse events.
Release Date: April 23, 2021
Expiration Date: April 23, 2022
This program will review current and emerging therapies for the management of patients with advanced NSCLC.
Release Date: April 28, 2021
Expiration Date: April 28, 2022
This activity will cover the treatment and management of patients locally-advanced or metastatic urothelial carcinoma.
Release Date: April 30, 2021
Expiration Date: April 30, 2022
The COVID-19 FRONTLINE TeleECHO session provides a comprehensive and up-to-date perspective on the ever-changing management of patients with COVID-19. This recording features in-depth case studies to encourage retention of the lessons and provide new perspectives on the management of patients during the COVID-19 pandemic. The case studies will focus on different issues facing clinicians, such as identifying patients who would benefit from monoclonal antibody therapy and best practices for incorporating agents authorized for emergency use into the care of hospitalized and non-hospitalized patients with COVID-19. Strategies for administering neutralizing monoclonal antibodies, such as referral to local infusion centers or developing in-clinic infusion capabilities, will also be discussed.
Release Date: May 3, 2021
Expiration Date: May 3, 2022
This activity will cover the treatment and management of patients with bladder cancer.
Release Date: May 7, 2021
Expiration Date: May 7, 2022
This case-based activity will cover the underlying causes of atopic dermatitis along with current and emerging systemic agents as part of the overall treatment plan.
Release Date: May 7, 2021
Expiration Date: May 7, 2022
This enduring activity will cover early detection and intervention in cancer.
Release Date: May 7, 2021
Expiration Date: May 7, 2022
This enduring activity will cover the treatment and management of patients with moderate-to-severe asthma.
Release Date: May 11, 2021
Expiration Date: May 11, 2022
This online activity targets healthcare gaps correlated with screening, multidisciplinary care and timely intervention in diabetic retinopathy (DR), which can impact vision-related quality of life.
Release Date: May 11, 2021
Expiration Date: May 11, 2022
The COVID-19 FRONTLINE Grand Rounds series provides a comprehensive and up-to-date perspective on the ever-changing management of patients with COVID-19. Each Grand Rounds session features in-depth case studies to encourage retention of the lessons and provide new perspectives on the management of patients during the COVID-19 pandemic. This program will focus on optimizing outcomes for hospitalized and nonhospitalized patients with COVID-19 through the use of novel agents authorized for emergency use.
Release Date: May 11, 2021
Expiration Date: May 11, 2022
This enduring, case-based activity will explore the role of screening and surveillance for patients with esophageal cancer (EC) and review clinical trial data on the efficacy and safety of immune checkpoint inhibitors as adjuvant treatment and across lines of therapy.
Release Date: May 21, 2021
Expiration Date: May 21, 2022
COVID-19 FRONTLINE podcasts provide a comprehensive and up-to-date perspective on the ever-changing management and prevention of COVID-19. Each podcast focuses on different issues facing clinicians and patients, such as managing patients with COVID-19, addressing the care of special populations during the pandemic, and coping with the long road to recovery.
Release Date: May 28, 2021
Expiration Date: May 28, 2022
This online activity targets healthcare gaps correlated with screening, multidisciplinary care and timely intervention in age-macular degeneration (AMD), which can impact vision-related quality of life.
Release Date: May 28, 2021
Expiration Date: May 28, 2022
This program will explore the use of vaccines and monoclonal antibody therapies for the prevention and treatment of patients with COVID-19. Innovative virtual reality animations will delve into the mechanism of action of emerging vaccines and monoclonal antibodies, the rationale for early administration of monoclonal antibodies in recently infected and uninfected individuals, and compare active and passive immunity.
Release Date: June 2, 2021
Expiration Date: June 2, 2022
This program will explore the use of polyclonal and monoclonal antibody therapies for the treatment of patients with COVID-19. Innovative virtual reality animations will delve into the mechanism of action of antibody therapies, the impact of SARS-CoV-2 variants on treatment efficacy, and the role of dual monoclonal antibody cocktails in the prevention of viral escape.
Release Date: June 2, 2021
Expiration Date: June 2, 2022
This COVID-19 FRONTLINE Whiteboard Module will explore the role of emerging SARS-CoV-2 variants and their potential impact on the efficacy of current monoclonal antibody therapies and vaccines authorized for emergency use in managing the COVID-19 pandemic. We will focus on SARS-CoV-2 viral variants and emerging clinical data of their impact on vaccines and monoclonal antibodies currently authorized for emergency use. A whiteboard animation will be used to enhance the learning experience of this activity.
Release Date: June 2, 2021
Expiration Date: June 2, 2022
This COVID-19 Snapshot will explore the role of emerging SARS-CoV-2 variants and their potential impact on the efficacy of current monoclonal antibody therapies and vaccines authorized for emergency use in managing the COVID-19 pandemic.
In this module, we will discuss mutations in the spike protein of SARS-CoV-2 viral variants and the potential impact of these alterations on the efficacy of current vaccines and monoclonal antibodies authorized for emergency use management of the COVID-19 pandemic. We will also share resources and tools for the administration of monoclonal antibody infusion therapies, as well as programs and initiatives developed to improve the ease and access of diagnostic technologies across the United States.
Release Date: June 2, 2021
Expiration Date: June 2, 2022
This case-based online enduring will focus on treatment and management of patients with advanced/metastatic basal cell skin cancer.
Release Date: June 3, 2021
Expiration Date: June 3, 2022
This online activity will explore the management of patients with nontuberculous mycobacterial lung disease (NTM-LD), including diagnosis, therapy selection, and strategies for assessing and treating patients with refractory disease.
Release Date: June 3, 2021
Expiration Date: June 3, 2022
This case-based activity will cover the epidemiology, pathophysiology, diagnosis, and treatment of eosinophilic esophagitis.
Release Date: June 16, 2021
Expiration Date: June 16, 2022
This enduring, case-based activity targets health care gaps related to the underlying autoimmune causes of alopecia areata (AA) and targeted treatment approaches, which can have a profound impact on health-related quality of life through burden of disease and associated comorbidities.
Release Date: June 16, 2021
Expiration Date: June 16, 2022
COVID-19 FRONTLINE podcasts provide a comprehensive and up-to-date perspective on the ever-changing management and prevention of COVID-19. Each podcast focuses on different issues facing clinicians and patients, such as managing patients with COVID-19, addressing the care of special populations during the pandemic, and coping with the long road to recovery.
Release Date: June 21 2021
Expiration Date: June 21, 2022
This online activity will evaluate clinical trial data on the use of monoclonal antibodies for the treatment and prevention of COVID-19 and review up-to-date information on the impact of circulating SARS-CoV-2 variants on treatment efficacy.
Release Date: June 25, 2021
Expiration Date: June 25, 2022
This online activity will explore best practices for the use of monoclonal antibodies for the treatment of COVID-19.
Release Date: June 25, 2021
Expiration Date: June 25, 2022
This online activity targets healthcare gaps correlated with screening, multidisciplinary care and timely intervention in retinal vein occlusion (RVO), which can impact vision-related quality of life.
Release Date: June 30, 2021
Expiration Date: June 30, 2022
This online activity will be a faculty-led didactic and case-based lecture focusing on treatment and management of patients with renal cell carcinoma.
Release Date: June 30, 2021
Expiration Date: June 30, 2022
Release Date: June 30, 2021
Expiration Date: June 30, 2022
This online activity will be a faculty-led didactic and case-based lecture focusing on treatment and management of patients with renal cell carcinoma.
Release Date: July 1, 2021
Expiration Date: July 1, 2022
The case-based online activity will cover the treatment and management of patients with TRK fusion-positive cancers.
Release Date: July 9, 2021
Expiration Date: July 9, 2022
The COVID-19 FRONTLINE VA Grand Rounds online activity provides a comprehensive and up-to-date perspective on the ever-changing management of patients with COVID-19. The online session features in-depth case studies to encourage retention of the lessons and provide new perspectives on the management of patients during the COVID-19 pandemic, and will focus on optimizing outcomes for hospitalized and non-hospitalized patients with COVID-19 through the use of novel agents authorized for emergency use.
Release Date: July 12, 2021
Expiration Date: July 12, 2022
This activity will cover the diagnosis and management of patients with influenza.
Release Date: July 15, 2021
Expiration Date: July 15, 2022
This case-based enduring activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.
Release Date: July 19, 2021
Expiration Date: July 19, 2022
This case-based enduring activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.
Release Date: July 19, 2021
Expiration Date: July 19, 2022
This enduring activity targets healthcare gaps related to the treatment and management of atrial fibrillation (AF), impacting outcomes through guidelines and best practices, appropriate antiarrhythmic use, and shared decision-making.
Release Date: July 20, 2021
Expiration Date: July 20, 2022
This online activity targets healthcare gaps correlated with screening, multidisciplinary care and timely intervention in diabetic retinopathy (DR), which can impact vision-related quality of life.
Release Date: July 20, 2021
Expiration Date: July 20, 2022
This online activity targets healthcare gaps correlated with screening, multidisciplinary care and timely intervention in age-macular degeneration (AMD), which can impact vision-related quality of life.
Release Date: July 21, 2021
Expiration Date: July 21, 2022
This program will review current and emerging immunotherapies for the management of patients with advanced NSCLC.
Release Date: July 21, 2021
Expiration Date: July 21, 2022
This enduring activity is focused on the team involved in the management of patients with familial hypercholesterolemia.
Release Date: July 22, 2021
Expiration Date: July 22, 2022
This online activity targets healthcare gaps correlated with screening, multidisciplinary care and timely intervention in retinal vein occlusion (RVO), which can impact vision-related quality of life.
Release Date: July 27, 2021
Expiration Date: July 27, 2022
This case-based live virtual activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.
Release Date: July 28, 2021
Expiration Date: July 28, 2022
This case-based live virtual activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.
Release Date: July 28, 2021
Expiration Date: July 28, 2022
This case-based live virtual activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.
Release Date: July 28, 2021
Expiration Date: July 28, 2022
This case-based live virtual activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.
Release Date: July 28, 2021
Expiration Date: July 28, 2022
This online activity is focused on the team involved in the management of patients with axial spondyloarthritis (AxSpa).
Release Date: July 31, 2021
Expiration Date: July 31, 2022
This case-based enduring activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.
Release Date: August 10, 2021
Expiration Date: August 10, 2022
This program provides a comprehensive and up-to-date perspective on the ever-changing management of patients with COVID-19 who present to the emergency department. The session features in-depth case studies to encourage retention of the lessons and provide new perspectives on the management of patients during the COVID-19 pandemic. The case studies will focus on different issues facing clinicians, such as identifying patients who would benefit from monoclonal antibody therapy and best practices for incorporating agents authorized for emergency use into the care of hospitalized and non-hospitalized patients with COVID-19. Strategies for administering neutralizing monoclonal antibodies, such as referral to local infusion centers or developing in-clinic infusion capabilities, will also be discussed.
Release Date: August 11, 2021
Expiration Date: August 11, 2022
This case-based enduring activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.
Release Date: August 20, 2021
Expiration Date: August 20, 2022
This enduring education is designed to help dermatologists, allergists, immunologists, primary care physicians, and other health care professionals in the Department of Veterans Affairs to identify the signs and symptoms of atopic dermatitis in adult patients, assess disease severity, incorporate updated guidance on the use of systemic therapy for atopic dermatitis during the COVID-19 pandemic into clinical practice, and utilize shared decision making to help individualize care.
Release Date: August 26, 2021
Expiration Date: August 26, 2022
This enduring activity is focused on the team involved in the management of patients with familial hypercholesterolemia.
Release Date: August 30, 2021
Expiration Date: August 30, 2022
This enduring activity will cover early detection and intervention in prostate cancer.
Release Date: August 30, 2021
Expiration Date: August 30, 2022
This activity will explore the management of patients with newly diagnosed, relapsed/refractory, and secondary acute myeloid leukemia (AML).
Release Date: September 7, 2021
Expiration Date: September 7, 2022
This case-based activity will cover the pathophysiology, point-of-care testing, and antiviral therapy for treating patients who present to the Emergency Department.
Release Date: September 16, 2021
Expiration Date: September 16, 2022
This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of diabetic retinopathy (DR), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
Release Date: September 17, 2021
Expiration Date: September 17, 2022
This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of diabetic retinopathy (DR), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
Release Date: September 17, 2021
Expiration Date: September 17, 2022
This enduring activity is focused on the team involved in the management of patients with familial hypercholesterolemia.
Release Date: September 20, 2021
Expiration Date: September 20, 2022
This enduring activity will cover the care and treatment of patients with moderate-to-severe atopic dermatitis.
Release Date: September 21, 2021
Expiration Date: September 21, 2022
This activity consists of presentations from expert faculty and 3D animation technology to discuss the pathology of small cell lung cancer (SCLC), clinical trial data of therapy in the second-line setting of SCLC, and clinical practice guidelines for the management of extensive disease.
RELEASE DATE: September 27, 2021
EXPIRATION DATE: September 27, 2022
This activity will cover the assessment, monitoring, and treatment of chronic lymphocytic leukemia (CLL) in the Department of Veterans Affairs.
Release Date: September 29, 2021
Expiration Date: September 29, 2022
This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of age-related macular degeneration (AMD), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
RELEASE DATE: October 01, 2021
EXPIRATION DATE: October 01, 2022
This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of age-related macular degeneration (AMD), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
RELEASE DATE: October 01, 2021
EXPIRATION DATE: October 01, 2022
This online activity targets healthcare gaps related to the recognition, prevention, and management of diabetic retinopathy (DR). An expert panel discussion will guide you in identifying candidates for anti-VEGF therapy, review clinical trial data on the use of these agents, and provide evidence-based strategies to individualize the management of DR and overcome treatment barriers.
RELEASE DATE: October 01, 2021
EXPIRATION DATE: October 01, 2022
This activity consists of presentations from expert faculty and 2D animation technology to explain immune dysfunction and the pathogenesis of non-small cell lung cancer (NSCLC), currently available and emerging immuno-oncology used alone and in combination with chemotherapy for NSCLC, and the usefulness and application of biomarkers to guide treatment selection for NSCLC.
RELEASE DATE: October 06, 2021
EXPIRATION DATE: October 06, 2022
This enduring activity will review clinical trial data on the efficacy and safety of monoclonal antibodies and vaccines authorized for use in the treatment and prevention of COVID-19, and highlight and address healthcare disparities during the COVID-19 pandemic.
RELEASE DATE: October 08, 2021
EXPIRATION DATE: October 08, 2022
This program will explore the management of “off” episodes in patients with Parkinson’s disease. Interactive case studies presented by expert faculty will evaluate pharmacologic approaches to reduce daily off time, including the efficacy and safety of on-demand therapies. Engaging whiteboard animation will review the pathophysiology of off episodes and the mechanism of action of treatment options.
RELEASE DATE: October 08, 2021
EXPIRATION DATE: October 08, 2022
This activity will cover the assessment, monitoring, and treatment of patients with severe uncontrolled asthma within the Department of Veterans Affairs.
RELEASE DATE: October 12, 2021
EXPIRATION DATE: October 12, 2022
PROGRAM CHAIR Robert Toto, MD Professor of Internal Medicine and Nephrology Director, Clinical Nephrology Director, Patient-Oriented Research in Nephrology Dallas, TX SPEAKING FACULTY Richard E. Pratley, MD Samuel E. Crockett
This case-based live-virtual activity will cover the treatment and management of patients with severe asthma.
RELEASE DATE: October 15, 2021
EXPIRATION DATE: October 15, 2022
This activity is designed to meet the educational needs of primarily dermatologists, onco-dermatologists, and also medical oncologists, Mohs surgeons, and other healthcare practitioners who care for patients with advanced/metastatic basal cell skin cancer.
RELEASE DATE: October 20, 2021
EXPIRATION DATE: October 20, 2022
This program will explore the management of off episodes in patients with Parkinson’s disease. Interactive case studies presented by ex pert faculty will evaluate pharmacologic approaches to reduce daily off time, including the efficacy and safety of on-demand therapies. Engaging whiteboard animation will review the pathophysiology of off episodes and the mechanism of action of treatment options.
RELEASE DATE: October 21, 2021
EXPIRATION DATE: October 21, 2022
This live virtual symposium is focused on the team involved in the care of the people who undergo screening for cancer.
RELEASE DATE: October 22, 2021
EXPIRATION DATE: October 22, 2022
The case-based online activity will cover the treatment and management of patients with severe asthma.
RELEASE DATE: October 27, 2021
EXPIRATION DATE: October 27, 2022
This program will explore the use of systemic therapies for the management of moderate-to-severe atopic dermatitis in pediatric and adult patients.
RELEASE DATE: October 27, 2021
EXPIRATION DATE: October 27, 2022
This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of retinal vein occlusion (RVO), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
RELEASE DATE: October 29, 2021
EXPIRATION DATE: October 29, 2022
This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of retinal vein occlusion (RVO), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
RELEASE DATE: October 29, 2021
EXPIRATION DATE: October 29, 2022
This activity will cover the assessment, monitoring, and treatment of Acute Myeloid Leukemia (AML).
RELEASE DATE: November 12, 2021
EXPIRATION DATE: November 12, 2022
This enduring activity will cover the treatment and management of patients with moderate to severe asthma.
RELEASE DATE: November 16, 2021
EXPIRATION DATE: November 16, 2022
This activity will cover the assessment, monitoring, and treatment of patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas.
RELEASE DATE: November 16, 2021
EXPIRATION DATE: November 16, 2022
This case-based online activity will cover the treatment and management of patients with hepatocellular carcinoma (HCC).
RELEASE DATE: November 18, 2021
EXPIRATION DATE: November 18, 2022
This enduring activity will cover the treatment of patients with neuromyelitis optica spectrum disorder.
RELEASE DATE: November 18, 2021
EXPIRATION DATE: November 18, 2022
This virtual satellite symposium discusses best practices for managing people with influenza who are at high risk for developing pulmonary complications. 2D animation technology is incorporated throughout the program to highlight the mechanism of action of point-of-care tests (POCTs) and antiviral treatments approved for treatment. Clinical data supporting the efficacy of antivirals and guidance on their use will also be provided.
RELEASE DATE: November 19, 2021
EXPIRATION DATE: November 19, 2022
In this virtual program, we will explore the management of Parkinson’s disease psychosis (PDP)–a condition that affects a substantial percentage of patients with Parkinson’s disease, typically in the later stages. Through this interactive program, clinicians will recognize symptoms, features, and diagnostic best practices in PDP. In addition, participants will learn about the underlying pathophysiology of PDP and treatments targeting these underlying pathways pivotal to the progression of PDP. Through an improved understanding of PDP, clinicians will gain insights and tools to better manage patients with PDP. Through interactive case studies presented by expert faculty, learners will be able to better evaluate pharmacologic approaches to PDP management and the efficacy and safety of approved therapeutic options. In addition, engaging whiteboard animations presented throughout will reinforce concepts learned in didactic portion, ensuring that participants understand the pathophysiology and mechanisms involved in pharmacologic management of PDP.
RELEASE DATE: November 26, 2021
EXPIRATION DATE: November 26, 2022
The case-based online activity will cover the treatment and management of patients with chronic and diabetic kidney disease (DKD).
RELEASE DATE: November 30, 2021
EXPIRATION DATE: November 30, 2022
Upon the completion of this program, attendees should be able to:
RELEASE DATE: December 01, 2021
EXPIRATION DATE: December 01, 2022
This enduring program consists of presentations from expert faculty and simulation challenge animations that will explain immune dysfunction and the pathogenesis of moderate-to-severe asthma, currently available and emerging targeted therapies used for asthma, and the usefulness and application of guidelines and biomarkers to guide treatment selection for this disease.
RELEASE DATE: December 07, 2021
EXPIRATION DATE: December 07, 2022
This enduring virtual TeleECHO program will explore the management of small cell lung cancer (SCLC) in the second-line setting. A brief didactic presentation will discuss treatment options after relapse of SCLC and will assess clinical trial data regarding the efficacy and safety of second-line treatment regimens. Interactive case studies will illustrate the application of guideline recommendations for treatments approved for managing extensive-stage SCLC.
RELEASE DATE: December 07, 2021
EXPIRATION DATE: December 07, 2022
Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.
Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.
Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.
